Page contents Key factsDecisionKey facts Active Substance carbacholbrimonidine tartrate Therapeutic area Eye disorders Decision number P/0160/2024 PIP number EMEA-003561-PIP01-23 Pharmaceutical form(s) Eye drops, solution Condition(s) / indication(s) Treatment of presbyopia Route(s) of administration Ophthalmic use Contact for public enquiries Visus Therapeutics Inc.E-mail: nathan.wheeler@visustx.com Tel.: +1 (949)2592259 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 06/05/2024DecisionP/0160/2024: EMA decision of 6 May 2024 on the granting of a product specific waiver for carbachol / brimonidine tartrate (EMEA-003561-PIP01- 23)Reference Number: EMA/176533/2024 English (EN) (220.6 KB - PDF)First published: 11/06/2025ViewShare this page